The HPV-SEQ is a clinical grade, ultra-sensitive liquid biopsy solution for the identification and quantification of circulating HPV 16 and HPV 18 DNA in patients with cancers caused by HPV infection, including cervical cancer, anal squamous cell carcinoma, and head and neck squamous cell cancer. HPV-SEQ detects cell-free HPV DNA (cfHPV-DNA) across a large dynamic range and demonstrates accurate quantification even when few copies are present, enabling high-resolution molecular monitoring.
HPV causes several different malignancies, including cervical cancer, anal squamous cell carcinoma, and head and neck squamous cell carcinoma. For example, HPV 16 causes the majority of oropharyngeal cancer in the United States1. HPV DNA detection in plasma using HPV-SEQ enables precise tracking of disease burden and response to therapy in patients with HPV-associated cancer.